Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.

about

Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.

Item

http://www.wikidata.org/entity/Q47697833

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cognitive functioning followin ...... non-randomized clinical trial.

@en

Cognitive functioning followin ...... non-randomized clinical trial.

@nl

type

Item

label

Cognitive functioning followin ...... non-randomized clinical trial.

@en

Cognitive functioning followin ...... non-randomized clinical trial.

@nl

prefLabel

Cognitive functioning followin ...... non-randomized clinical trial.

@en

Cognitive functioning followin ...... non-randomized clinical trial.

@nl

P1476

Cognitive functioning followin ...... non-randomized clinical trial.

@en

P2093

C Petersen

http://www.w3.org/2001/XMLSchema#string

P C Nilsson

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

The hospital anxiety and depression scale

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.

Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting

Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.

A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients

P304

117-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12833

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

I Rorsman

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28901547

http://www.w3.org/2001/XMLSchema#string